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Hair bulb keratinocytes generate one of the few ‘‘immune
privileged’’ tissue compartments of the mammalian
organism by suppressing classical MHC class I (MHC Ia)
antigens. Expression of non-classical MHC class I (MHC
Ib) antigens in the follicle has been found, but only in its
distal epithelium. Here, we have defined when during
murine hair follicle morphogenesis these peculiar MHC
Ia and Ib expression patterns are established, how they
change during the murine hair cycle, and how different
MHC I modulatory agents alter follicular MHC Ia and
Ib expression in vivo. During neonatal hair follicle mor-
phogenesis in C57BL/6 mice, distal follicle keratinocytes
began to express MHC Ia (H2b) only late in development.
The MHC Ib antigens, Qa-1 and Qa-2, did not become
visible until the initiation of follicle cycling, with Qa-1
expression being more widespread than that of Qa-2.
H2b, Qa-1, and TAP-1 immunoreactivity on previously
In the ongoing quest to better define the as yet obscureimmunology of the hair follicle (HF), one of the key challengesof ‘‘trichoimmunology’’ is to elucidate the controls and func-tional significance of the peculiar expression pattern of majorhistocompatibility complex (MHC) class I molecules of the
follicle epithelium (Paus, 1997).
The expression of classical MHC class I molecules (MHC Ia) is
essential for ‘‘self’’-recognition by the immune system, and almost all
nucleated cells present intracytoplasmatically synthesized peptides to
MHC class I-restricted CD81 T lymphocytes (Paul, 1993; Janeway
and Travers, 1996). Proteins are degraded by proteasomes within the
cytoplasm, and are then transported into the endoplasmatic reticulum
by transporter in antigen processing (TAP)-1 and TAP-2 molecules
(York and Rock, 1996; Elliott, 1997). Functional MHC class I
molecules are highly polymorphic and consist of three components:
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negative keratinocytes of the proximal anagen hair bulb
was upregulated by intradermal injection of the proin-
flammatory cytokine interferon-g, but not by tumor
necrosis factor-a or interleukin-1b. Injection of the
reportedly MHC class I downregulating agents inter-
leukin-10, insulin-like growth factor-1, transforming
growth factor-b, a-melanocyte stimulating hormone,
or dexamethasone, however, all failed to downregulate
constitutive or interferon-g-induced follicular MHC Ia
expression. This shows that the hair follicle is a previously
unrecognized site of Qa-1 expression and that interferon-
g is a key regulator of follicular MHC I expression in vivo.
It also suggests that the developmental and immunologic
controls of MHC I expression by follicle keratinocytes
differ from those of other epithelial cells. Key words:
alopecia areata/a-MSH/IFN-g/IL-1b/immune privilege/Qa-
1/Qa-2/TAP-1/TNF-a. J Invest Dermatol 111:25–30, 1998
the 45 kDa transmembrane heavy chain, the soluble light chain beta-
2 microglobulin (β2m), and the peptide ligand, delivered by the TAP
molecules (Parham and Ohta, 1996; Elliott, 1997). In the case of
abnormal ‘‘non-self’’ proteins, produced within the cell in the course
of viral infection or during malignant transformation, these proteins
are presented by MHC class I molecules and recognized by CD81 T
lymphocytes, which usually remove the corresponding cells by various
cytotoxic mechanisms (Paul, 1993; Janeway and Travers, 1997).
A few organs or tissue compartments, however, display a so-called
‘‘immune privilege’’ characterized by a lack of MHC Ia expression,
which prevents recognition and elimination of stringently selected cell
populations by CD81 cytotoxic T lymphocytes. The tightly regulated
suppression of self-peptide presentation is well documented in the
central nervous system, fetotrophoblast, testis, and the anterior eye
chamber, where a breakdown of immune privilege leads to an
inflammatory autoimmune attack, causing severe tissue damage and
functional defects (Streilein, 1993; Brent, 1997; Janeway and Travers,
1997).
Intriguingly, the proximal (lower) epithelium of growing HF, i.e.,
the anagen hair bulb, also appears to be an immunologically privileged
tissue site (Billingham and Silvers, 1971; Paus and Link, 1988), because
it lacks significant MHC Ia expression and, in mice (Paus et al, 1998),
does not contain antigen presenting cells (Harrist et al, 1983; Bro¨cker
et al, 1987; Westgate et al, 1991; Paus et al, 1994a; Paus, 1997). Like
other immunoprivileged tissues, the proximal anagen hair bulb also
displays a very special extracellular matrix environment, which may
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further hinder immune recognition of follicular autoantigens (cf.
Westgate et al, 1991), and expresses immunosuppressive molecules like
transforming growth factor (TGF)-β (Wollina et al, 1996) and α-
melanocyte stimulating hormone (α-MSH) (Luger et al, 1998).1
Clinically, follicular immune privilege may be important, because a
collapse of the normal MHC Ia negativity of the proximal anagen hair
bulb might be an early key event in the pathogenesis of alopecia areata,
where a breakdown of the bulbar immune privilege by pathologic
upregulation of MHC Ia expression may allow the recognition of
normally sequestered follicular autoantigens by autoreactive, cytotoxic
T cells, thus initiating the characteristic autoimmune attack against
anagen HF (Paus et al, 1994c). Indeed, mice treated with transfected,
IL-2-secreting melanoma cells develop an alopecia areata-like hair loss
associated with ectopic upregulation of MHC Ia in the anagen hair
bulb (Becker et al, 1996). IL-2, however, is not appreciated as a direct
upregulator of MHC class I expression, whereas it can induce the
release of other classical upregulators of MHC Ia expression like
interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin
(IL)-1β (Paul, 1993; Seder and Paul, 1994). The most interesting
candidate for upregulating MHC Ia in the hair follicle under pathologic
conditions is IFN-γ, because it induces MHC class I and β2m expression
as well as intracellular protein degradation in most cell lineages (Yang
et al, 1992; Gaczynska et al, 1993), and even on immune privileged,
MHC Ia-negative neurons (Neumann et al, 1995).
In addition to ‘‘classical’’ MHC class I molecules (MHC Ia) like
H2b, several ‘‘non-classical,’’ MHC-gene encoded proteins and MHC-
associated antigen presenting molecules are now appreciated. The
major differences between classical and non-classical MHC class I
molecules (MHC Ib), e.g., Qa-1 and Qa-2 in the mouse, are the
restricted polymorphism, the much more restricted tissue distribution
pattern, and the lower levels of surface expression of the latter
(Stroynowski, 1995; Tangri et al, 1996). The tissue distribution of
MHC Ib is widely thought to be mainly limited to the lymphoid
system (Soloski et al, 1995; Stroynowski, 1995). We have, however,
previously detected a strong, selective expression of Qa-2 in the distal
outer root sheet (ORS) of the murine hair follicle epithelium in
adolescent mice (Paus et al, 1994b), where it may serve as part of a
phylogenetically ancient component of the HF immune system. Here,
Qa-2 may present conserved bacterial antigens to γδ T cell receptor-
bearing lymphocytes (Stroynowski, 1995) that are also located in this
area (Paus et al, 1994a, 1997).
In order to define when during neonatal HF morphogenesis these
peculiar MHC Ia and Ib expression patterns are established, and to
explore which cytokines may control their expression in vivo, we
have followed up and complemented in this study our previous
characterization of H2b, H2Db, and Qa-2 expression during the
adolescent murine hair cycle (Paus et al, 1994a). H2b, TAP-1, Qa-1,
and Qa-2 expression during neonatal HF morphogenesis and expression
of Qa-1 during the induced murine hair cycle in adolescent animals were
characterized in C57BL/6 mice by immunohistology. By intradermal
injection of IFN-γ, TNF-α, and/or IL-1β, it was tested whether these
proinflammatory cytokines can upregulate the expression of any of
these antigen-presenting molecules in the MHC Ia-negative anagen
hair bulb in vivo. Vice versa, we tested whether previously reported
downmodulators of MHC Ia expression (IL-10, α-MSH, IGF-1, TGF-
β) (Geiser et al, 1993; Luger et al, 1998) also have such an effect in
the strongly and homogeneously MHC Ia1 epithelium of telogen HF.
These analyses provide novel insights into the unique MHC I expression
milieu of the HF as an integral part of the emerging HF immune
system (Paus, 1997; Paus et al, 1998).
MATERIALS AND METHODS
Animals For the analysis of MHC class I expression during neonatal HF
morphogenesis, 1–21 d old neonatal C57BL/6 mice, obtained from the animal
facilities of the Charite´ Hospital (Berlin, Germany) were studied. MHC class I
1Roloff B, Botchkarev V, Slominski A, Luger T, Paus R: Is α-melanocyte
stimulating hormone (α-MSH) involved in hair growth control? J Invest Dermatol
111:533, 1998 (abstr.)
expression during adolescent HF cycling was studied in 7–8 wk old female
C57BL/6 mice (Charles River, Sulzfeld, Germany) with all back skin HF in
telogen (Paus et al, 1990). All experimental groups consisted of at least four
mice per stage of follicle morphogenesis and cycling, and all experiments were
repeated at least twice.
In vivo treatment Synchronized anagen was induced by depilation as previ-
ously described (Paus et al, 1990). For experiments testing the upregulatory
effects of various cytokines on MHC class I expression, adolescent test- and
control mice were used on day 13 after depilation, i.e., when all back skin HF
had fully developed into anagen VI follicles (Paus et al, 1990). The following
proinflammatory cytokines, which are known to strongly upregulate MHC Ia
expression in various experimental systems (Israel et al, 1986, 1989; Kuby,
1997), were injected intradermally twice within 4 h into the back skin in
100 µl phosphate buffered saline containing 0.1% bovine serum albumin: 10 µg
TNF-α (R&D Systems, Wiesbaden, Germany), 500 ng IL-1β (R&D Systems),
10,000 units IFN-γ (Sigma, Deisenhofen, Germany), and a ‘‘cocktail’’ with
equal parts of each cytokine. These high cytokine doses were purposely selected
in order to achieve maximal MHC Ia upregulatory activity. To study the MHC
Ia modulatory effects of a prolonged exposure to IFN-γ, a total of three
injections of 10,000 U IFN-γ i.c. was given into depilation-induced anagen
back skin, 9, 12, and 15 d after depilation. Skin was harvested on day 17 or 21
post-depilation, and was stained for MHC Ia expression and CD41 and CD81
lymphocytes in the resulting inflammatory cell infiltrate at the site of injection.
Controls received 100 µl phosphate buffered saline containing 0.1% bovine
serum albumin alone at the same time points.
To downregulate the normal, strong, and homogeneous follicular MHC Ia
expression in mice with all back skin follicles in telogen (Paus et al, 1994b), on
days 1, 2, and 3, 100 µg α-MSH (Sigma), 100 µg ‘‘super potent’’ α-MSH
analog (peptide 4–13; Sigma), 500 ng IL-10 (RD Systems), 1 µg IGF-1 (RD
Systems), and a combination of α-MSH, IGF-1, and IL-10 were injected
intradermally. For comparison, the effects of the potent immunosuppressant
dexamethasone-21-acetate on MHC class I expression was also studied by
topical application of an 0.1% solution (diluted in propylene glycol) (Paus et al,
1994d) on shaved back skin every 12 h. After 4 d, the skin of all groups
was harvested.
For downregulation or suppression of IFN-γ-induced ectopic MHC class I
expression (see Results), IFN-γ was injected together with the anti-inflammatory,
MHC class I downregulating cytokines IL-10 (500 ng), IGF-1 (1 µg), TGF-
β1 plus TGF-β3 (250 ng each), α-MSH (50 µg), the ‘‘super potent’’ α-MSH
analog (50 µg), or the combination of IL-10 (500 ng), IGF-1 (1 µg), and α-
MSH (50 µg) twice within 4 h together with IFN-γ. Alternatively, the above
doses of the anti-inflammatory agents were given 24 h after IFN-γ application.
In all cases, skin was harvested 24 h after the last cytokine application.
Skin harvesting and processing At the indicated time points after treatment,
mice were sacrificed and back skin was embedded and processed for longitudinal
cryosections through the HF as described (Paus et al, 1994a, b).
Immunohistology The primary antibodies applied during immunohistology
and their source, dilution, and host species are listed in Table I. The basic
immunohistology techniques followed our previously published protocols (Paus
et al, 1994b; Eichmu¨ller et al, 1996, 1998).
Negative controls were obtained by omission of primary antibody, as well as
by using nonspecific hamster or rat IgG instead of the primary antibody. Murine
thymus and spleen and brain sections, as well as murine skin itself, served as
positive and negative controls (Paul, 1993; Paus et al, 1994b; Janeway and
Travers, 1997). All these negative and positive controls for the antibodies
employed (Table I) yielded the immunoreactivity (IR) patterns expected from
the literature (not shown).
Immunofluorescence (TAP-1) Non-specific binding was blocked with 3%
murine normal serum and 2% goat normal serum. Overnight incubation with
a polyclonal rabbit anti-mouse TAP-1 (kindly provided by Klaus Fru¨h, Scripps
Research Institute, La Jolla, CA; Fru¨h et al, 1992) was followed by a secondary
incubation with rhodamine-labeled goat-anti-rabbit antibody (1:200; Dianova,
Hamburg, Germany) as described (Botchkarev et al, 1997a, b).
RESULTS
H2b expression during neonatal skin and HF development On
day 1 post-partum (p.p.) (stage 4 of HF morphogenesis; for details see
Paus et al, 1997), only a few cells in the dermis, along with all dermal
papilla (DP) fibroblasts of the developing HF, showed immunohisto-
logically detectable H2b expression (Fig 1a). H2b IR then slowly
increased on all dermal and subcutaneous cell populations, with
strongest expression noted on endothelial cells in the subcutis (Fig 1b).
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Table I. Primary antibodies, dilutions, and immunohistologic techniquesa
Antigen Mainly expressed by Source Species Dilution/technique
MHC Ia Almost all nucleated somatic cells Pharmingen, ER HR 52 Rat 1/400
(H2b) APAAP
Qa-1 T cells Kind gift of P. Robinson Rabbit 1:500
(Hammersmith Hospital, London, U.K.) polyclonal ABC-AP
Qa-2 Peripheral and thymic T cells Kind gift of P. Robinson Rabbit 1:1500
follicle KC (Mellor et al, 1991) monoclonal ABC-AP
TAP-1 Almost all somatic cells Kind gift of K. Fru¨h Rabbit 1/250
(MHC Ia transporter protein) (Fru¨h et al, 1992) IF
aIF, immunofluorescence; ABC-AP, avidin-biotin-alkaline-phosphatase-complex; APAAP, alkaline-phosphatase-anti-alkaline-phosphatase.
Figure 1. Expression of classical and non-
classical MHC class I molecules in the
murine HF during neonatal develop-
ment, and induction of MHC-expression
in anagen HF after cytokine treatment.
Scale bars: (a, c, e–o) 50 µm, (b, d) 100 µm.
DP, dermal papilla; HS, hair shaft; C, club
hair; SG, sebaceous gland; IRS, inner root
sheath; ORS, outer root sheath. (a) Weak
H2b staining in the dermis/subcutis/DP of
neonatal mice 1 day p.p. (stage 4); (b)
increasing H2b staining in the dermis/
subcutis, endothelial cells, and distal (upper)
ORS of the HF of neonatal mice 5 d p.p.
(stage 7); (c) H2b expression in the distal
follicle epithelium and the SG on day 19 p.p.
(catagen VIII); (d) Qa-2 expression in the DP
on day 3 p.p. (stage 6); (e) Qa-2 expression
in the distal follicle KC on day 15 p.p. (stage
8); (f) Qa-1 staining in the distal follicular
epithelium on day 12 p.p. (stage 8); (g) Qa-
1 expression on all follicle KC on day 21 p.p.
(telogen); (h) strong upregulation of H2b
expression in the anagen bulb KC 24 h after
IFN-γ treatment; (i) upregulation of H2b
expression in the proximal (lower) anagen hair
bulb 6 h after intradermal IFN-γ injection; (j)
H2b negativity in anagen hair bulb KC of
control mice; (k) weak constitutive expression
of TAP-1 in controls in the DP and the
ORS; (l) enhanced TAP-1 expression in the
proximal hair bulb 24 h after IFN-γ injection;
(m) failure of IL-1β to upregulate MHC Ia
expression in HF KC; (n) H2b expression
24 h after injection of IL-1β, TNF-α, and
IFN-γ; (o) Qa-1 upregulation in proximal
follicle KC 24 h after IFN-γ injection. Arrows
and arrowheads, see Results.
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HF showed H2b staining in the distal (upper) follicle epithelium
between the stem cell region (bulge) and the beginning of the
perifollicular epidermis, as well as in the DP on day 5 p.p. (stage 7)
(Fig 1b). H2b expression slowly increased around the time of the first
spontaneous follicle regression (catagen), i.e., when the life-long growth
and regression activity of the HF is initiated (Fig 1c: day 19 p.p.;
catagen VIII) (Paus, 1996; Paus et al, 1997). All follicle keratinocytes
(KC) were strongly H2b positive by day 21 p.p., i.e., when synchronized
HF cycling in mice had been initiated by the first entry of fully
developed stage 8 follicles into catagen (Paus et al, 1997). KC of the
neonatal epidermis and the developing hair bulb remained MHC Ia
negative during the first 14 d p.p. (Fig 1a, b).
By day 21 p.p., i.e., when most HF were in telogen, H2b appeared
uniformly expressed throughout all extrafollicular cutaneous cell popu-
lations. Sebaceous glands showed H2b IR first on day 9 p.p. (stage 8),
and remained MHC Ia1 ever thereafter.
Expression of Qa-1 and Qa-2 during neonatal skin and HF
development Previously, we have shown in adolescent mice that
the MHC Ib molecule Qa-2 is selectively expressed by distal ORS
KC (Paus et al, 1994a). Yet, no data were available on the expression
of Qa-1 in adolescent mice, and on the expression of both MHC Ib
antigens during neonatal murine HF morphogenesis. Interestingly, in
the early neonatal period (days 1–3 p.p.), C57BL/6 mouse HF displayed
weak Qa-2 immunoreactivity only in the DP (Fig 1d, arrow), which
disappeared again by day 7 p.p. (stage 8). By day 14 p.p. (stage 8),
µ10% of all back skin follicles began to express immunohistologically
detectable Qa-2 molecules around the infundibulum of the sebaceous
gland. On day 15 p.p., i.e., when all back skin HF had completed
morphogenesis and were in late stage 8, µ60% of all HF expressed
Qa-2 in the distal follicle epithelium between the stem cell region
(bulge) and the beginning of the perifollicular epidermis (Fig 1e,
arrows), i.e., in the pattern previously described for adolescent mice
(Paus et al, 1994b).
During spontaneous catagen development in infantile mice (days
16–18 p.p.), almost all follicles showed this expression pattern, which
is characterized by an absence of Qa-2 IR in the proximal hair bulb,
epidermis, DP, sebaceous gland, and all fibroblasts. Starting from day
16 p.p., some endothelial cells in the subcutaneous vasculature also
expressed Qa-2 IR (not shown). At day 21 p.p., Qa-2 expression by
distal ORS KC remained stable, with strongest immunoreactivity
detected around the infundibulum of the sebaceous gland. No Qa-2
positive cells could be detected in the epidermis and subcutis at this
time, whereas a few, isolated cells in the dermis, probably representing
macrophages, expressed Qa-2. This means that the definite Qa-2
expression pattern of murine HF is established by the time the HF
completes its development.
Qa-1 distribution in the adult HF resembled very closely that
described for Qa-2. Qa-1 expression in the distal follicle epithelium
and the sebaceous gland was first detectable on day 7 (stage 8) (Fig 1f,
arrows), with gradually increasing strength during further post-natal skin
and HF development, until on day 21 p.p. all follicle KC showed Qa-
1 IR in telogen (Fig 1g, arrows). The regressing follicle in the dermis/
subcutis on day 21 was surrounded by some strongly Qa-1 positive
cells, presumably representing macrophages.
Qa-1 expression during induced HF cycling During induced
pelage HF cycling in adolescent mice, Qa-1 IR was detected throughout
the entire hair cycle in distal follicle KC, comparable with the previously
described Qa-2 distribution (Paus et al, 1994b), whereas in late catagen
and in telogen the entire HF epithelium showed Qa-1 expression
(not shown).
Upregulation of H2b, Qa-1, and TAP-1 expression on anagen
hair bulb KC in situ by IFN-g Intradermal injection of IFN-γ
(10,000 U) induced a strong expression of MHC Ia (H2b) on all KC
in the normally MHC Ia negative proximal anagen hair bulb within
24 h of injection (Fig 1h, arrows). Already 6 h after the last IFN-γ
injection, a first, weak H2b IR could be detected in this region (Fig 1i,
arrows). Controls injected only with saline showed the expected MHC
Ia negativity of the KC in the anagen hair bulb, inner root shealth,
and matrix. This was contrasted by a weakly H2b1 ORS and a
prominently H2b1 DP, where IFN-γ treatment could not further
upregulate this MHC Ia expression (cf. Paus et al, 1994b) (Fig 1i, j,
arrowheads). Compared with the constitutive follicular TAP-1 IR in
vehicle controls (Fig 1k, arrows), MHC-associated TAP-1 proteins
were also strongly upregulated in the proximal hair bulb after IFN-γ
treatment (Fig 1l, arrows).
Injection of the proinflammatory cytokines IL-1β (500 ng) (Fig 1m)
and TNF-α (10 µg) failed to induce an immunohistologically detectable
MHC class I expression by proximal hair bulb KC in vivo (arrows),
even though biologic activity of these cytokines was evident from the
fact that they induced a strong intradermal inflammatory cell infiltrate,
with upregulation of LFA-1 and/or ICAM-1 (data not shown).
Injection of all three cytokines (IFN-γ, IL-1β, TNF-α) as a potent
‘‘pro-inflammatory cocktail’’ (Fig 1n) could not further increase MHC
class I expression, compared with IFN-γ treatment alone (arrows).
Interestingly, 24 h after IFN-γ injection, Qa-1 became strongly
expressed in the (otherwise Qa-1 negative) proximal anagen hair bulb
(Fig 1o). This IFN-γ-induced stimulation of Qa-1 expression by hair
bulb KC in situ was actually even more pronounced than the one of
H2b (cf. Fig 1h).
Qa-2 was not detectable in the proximal hair bulb even after
injection of IFN-γ, TNF-α, and/or IL-1β; however, Qa-2 showed a
slightly stronger IR in the distal HF epithelium after IL-1β, TNF-α,
and IFN-γ injection. This suggests that the surface expression of Qa-
2 on follicular KC in situ can be upregulated by pro-inflammatory
cytokines; however, the same cytokines fail to induce expression of
this MHC Ib molecule in constitutively Qa-2 negative cells. Repeated
injections of IFN-γ on days 9, 12, and 15 induced in addition to H2b
upregulation a strong inflammatory infiltrate, in which CD41 and
CD81 lymphocytes were prominently represented (not shown).
Failure of anti-inflammatory agents to downregulate follicular
MHC Ia expression In contrast to the abundance of data on
mechanisms that upregulate MHC Ia expression, very little is known
on the downregulatory controls of MHC I expression in vivo, and on
the mechanisms that underlie the constitutive lack of MHC Ia
expression by nucleated cells. Because selected anti-inflammatory agents
had been reported to downregulate the MHC Ia expression of various
cell types in vitro (Taylor et al, 1992; Geiser et al, 1993; Matsuda et al,
1994; Rajora et al, 1996; Luger et al, 1998), these agents were tested
for their effect on follicular H2b expression in vivo, studying murine
telogen HF with their strong, homogeneous MHC Ia expression
throughout the follicle epithelium. TGF-β, α-MSH, a ‘‘super potent’’
α-MSH analog with prolonged half-life, IL-10, IGF-1, or a combina-
tion of α-MSH, IGF-1, and IL-10 were injected intradermally. As an
additional control, the effect of topically administered dexamethasone-
21-acetate on MHC Ia expression of telogen follicles was studied;
however, all tested substances failed to downregulate H2b on the
surface of telogen HF or epidermal KC, as well as in normal KC of
the surrounding skin (not shown).
If an ectopic upregulation of MHC Ia molecules in the normally
MHC Ia-negative anagen hair bulb really is a key factor in the
pathogenesis of inflammatory hair growth disorders like alopecia areata
(Paus et al, 1994c; Becker et al, 1996), it would be clinically most
useful to downregulate cytokine-induced abnormal MHC Ia expression
in the proximal anagen hair bulb. Therefore, we also tested whether
intradermal injection of α-MSH, the α-MSH analog, IL-10, or TGF-
β1 combined with TGF-β3 twice within 4 h (together with the IFN-
γ injection, or given 24 h after the last IFN-γ treatment) blocked or
downregulated the IFN-γ-induced H2b expression in the proximal
anagen hair bulb in vivo; however, all these reported MHC Ia-
downmodulatory agents, once again failed to do so in murine anagen
hair bulb KC in situ (the H2b expression pattern after IFN-γ treatment,
followed by administration of these inflammatory agents, was identical
to the one shown in Fig 1h).
DISCUSSION
MHC class I molecules play an essential role in maintaining the
integrity of the skin and the whole organism, because virally transformed
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or malignant cells that produce non-‘‘self’’ peptides are removed by
MHC class I-dependent mechanisms (Janeway and Travers, 1997).
Non-classical MHC class Ib molecules may protect the organism from
infections by various pathogens: they may serve as an ancient anti-
infection defence system by presenting, for example, conserved bacterial
proteins to γδ T cells (Kurlander et al, 1992; Stroynowski, 1995).
This study has revealed a very restricted expression pattern of classical
and non-classical MHC class I molecules in murine skin and HF.
During the first days p.p., these molecules are expressed only on single
cells in the dermis and in the follicular DP. The gradually increasing
MHC I-IR, from birth to day 21 p.p., when almost all skin cells
express MHC I molecules, parallels the maturation of the skin immune
system. MHC Ia molecules are expressed at the end of stage 8 on
almost all KC of the distal HF epithelium, with the exception of some
MHC Ia negative cells in the proximal hair bulb. MHC Ib IR is
restricted to distal follicle KC, comparable with the expression pattern
seen in the adult HF.
This IR of non-classical MHC molecules in the periinfundibular
region correlates with the localization of intraepithelial γδ T cells in
the HF of adolescent C57BL/6 mice (Paus et al, 1994a). As Qa-1 and
Qa-2 molecules are high-stringency peptide receptors, they may present
epithelial-derived antigens to γδ T cells (Ro¨tzschke et al, 1993) located
in this area (Paus et al, 1994b). MHC Ib molecules may be involved
in host defence against bacteria, as some of these molecules can present
conserved bacterial antigens to cytotoxic T cells (Kurlander et al, 1992;
Sperling and Bluestone, 1993). The follicle canal and the infundibulum
of the sebaceous gland are preferred routes of entry for many pathogenic
organisms, e.g., from the resident microflora (Noble, 1993). MHC Ib
molecules, therefore, may be part of a primitive anti-bacterial defence
system of the HF (Paus, 1997), similar to their putative role in the
intestinal mucosa (Sperling and Bluestone, 1993).
To complement our study of MHC Ib expression in the adolescent
induced hair cycle (Paus et al, 1994b) we have studied the follicular
localization of Qa-1. Its IR pattern resembles closely that reported for
Qa-2, with additional expression of Qa-1 in the sebaceous gland. This
similar constitutive expression may indicate common functions for
both molecules in the HF immune system.
Although the functions of classical MHC I molecules are well
defined, the role and regulation of the immune privilege in anagen
hair bulb KC (Paus et al, 1994b, c) is ill-understood. Cell surface
expression of MHC I molecules is increased by pro-inflammatory
cytokines like IFN-γ or TNF-α. IFN-γ can even lead to a breakdown
of the neuronal immune privilege by upregulating MHC I expression
(Neumann et al, 1995). The regulation of classical MHC class I genes
is widely investigated, and many different regulatory functions for
IFN-γ are known. Transcription of the H2b gene is initiated by
induction of an interferon binding protein, which binds to the
interferon response sequence of the H2b promoter (Israel et al, 1986;
Blanar et al, 1989). The interferon binding protein is induced 45 min
after IFN-γ in vitro (Blanar et al, 1989) and MHC class I genes are
transcriptionally induced within 2–3 h.
By immunohistology, we were able to detect low levels of H2b
expression in previously H2b negative hair bulb KC 6 h after INF-γ
treatment. After 24 h, these KC show strong H2b expression, which
is consistent with the time course of maximal MHC Ia mRNA
induction after IFN-γ treatment described for endothelial cells (Epper-
son et al, 1992). This upregulation of MHC Ia and the resulting
collapse of the immune privilege of this HF region may render these
HF KC susceptible to recognition by CD81 cytotoxic T cells. This
could be relevant for the pathogenesis of alopecia areata, where such
an ectopic, IFN-γ-mediated upregulation of MHC Ia expression in
the anagen hair bulb has been postulated to be of central importance
(Paus et al, 1994b).
Upregulation of MHC Ib like Qa-2 by IFN-γ in vitro has been
demonstrated before in other systems (Israel et al, 1986; Warner et al,
1993; Colgan et al, 1996). The de novo induction of Qa-1 expression
in the previously Qa-1 negative anagen hair bulb by IFN-γ reported
here suggests a similar regulation as for H2b. Both MHC Ia and MHC
Ib molecules were upregulated by all pro-inflammatory cytokines
tested; however, in contrast to H2b or Qa-1, none of these cytokines
could upregulate Qa-2 expression in Qa-2-negative follicle compart-
ments. This suggests that the regulation of Qa-2 transcription and
expression differs substantially from the one of H2b and Qa-1.
In line with what has been described for endothelial cells (Epperson
et al, 1992), TAP-1 was upregulated in parallel with the H2b molecules
in the proximal bulb KC (24 h after IFN-γ injection). Taken together
with the reported upregulation of proteasomes, which deliver degraded
endogenous peptides from the cytoplasm (Yang et al, 1992; Gaczynska
et al, 1993), the results presented here suggest that IFN-γ is able to
induce all necessary molecules for regular MHC Ia surface expression.
Because transgenic mice with intraepithelial overexpression of IFN-γ
show massive hair loss (Carroll et al, 1997), it will be interesting to
study to what extend this is related to an abnormal, IFN-γ mediated
upregulation of MHC Ia in the proximal hair bulb and the resulting
consequences of a collapse of the MHC Ia-based follicular immune
privilege.
The reportedly synergistic effects of TNF-α and IFN-γ treatment
on the upregulation of MHC class I expression in normal somatic cells
(Lapierre et al, 1988; Johnson and Pober, 1990, 1994) could not be
verified in murine hair bulb KC in vivo: the expression of H2b after
joint injection of IFN-γ, TNF-α, and IL-1β was not stronger than
after IFN-γ injection alone. This suggests that IFN-γ is the key
determinant for controlling MHC I expression in the HF. Induction
of MHC molecules by IFN-γ seems to be a very powerful stimulus
for the transcription and expression of MHC gene-related molecules,
and different mediators reported to downregulate MHC class I expres-
sion failed to do so in IFN-γ treated hair bulb KC. The inhibitory
activity of TGF-β (Geiser et al, 1993), IL-10 (Matsuda et al, 1994), α-
MSH (Luger et al, 1998), and IGF-1 (Saji et al, 1992) on MHC Ia
expression, previously reported for several in vitro systems (Geiser et al,
1993; Matsuda et al, 1994; Luger et al, 1998), could not be verified
for epidermal and HF KC in mice. This negative result suggests that
cell culture data on MHC Ia regulation are not necessarily transferable
to the more complex in vivo situation, but may also reflect methodologic
problems like the injection dose or schedule employed here.
In summary, our study shows that the MHC Ia-based immune
privilege of the proximal hair bulb develops only late on during HF
morphogenesis, that the HF is the site of developmentally controlled
MHC Ib expression (with Qa-1 and Qa-2 showing differences in their
regulation by IFN-γ), and that HF KC differ from other epithelial cells
in their control of MHC I expression.
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